Skip to main content
Contact Us
Subscribe
E-Edition
75°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcus Biosciences Inc
(NY:
RCUS
)
15.89
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcus Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Dow Jumps 150 Points; Crude Oil Rises 1%
December 20, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Tuesday.
Via
Benzinga
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 20, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...
Via
Benzinga
Where Arcus Biosciences Stands With Analysts
December 20, 2022
Via
Benzinga
Expert Ratings for Arcus Biosciences
November 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 20, 2022
Via
Benzinga
Nasdaq Edges Lower; Gold Rises 1.5%
December 20, 2022
U.S. stocks traded mixed midway through trading, with the S&P 500 and the Nasdaq Composite moving lower on Tuesday.
Via
Benzinga
Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday
December 20, 2022
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche
December 20, 2022
Gilead and Arcus toppled Tuesday after their lung-cancer regimen trailed a rival concoction from Roche.
Via
Investor's Business Daily
US Stocks Edge Higher; Dow Rises 50 Points
December 20, 2022
U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 50 points on Tuesday.
Via
Benzinga
Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients
December 20, 2022
Via
Benzinga
Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study
December 19, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
December 09, 2022
From
Arcus Biosciences
Via
Business Wire
Optimism Building for Advancing Pancreatic Cancer Treatment Therapies
December 01, 2022
EQNX::TICKER_START (NASDAQ:ONCY),(NYSE:RCUS),(NASDAQ:AZN),(NYSE:BMY),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
Gilead's Cancer Program Notches Another Win, But It's Arcus Stock That Surges
November 28, 2022
Gilead and Arcus notched another win for their cancer program on Monday. GILD stock briefly hit a four-year high as RCUS stock gapped higher.
Via
Investor's Business Daily
Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures
November 28, 2022
Via
Benzinga
Gilead and Arcus Biosciences Announce Positive Update on Joint TIGIT Program From Interim Analysis of ARC-7 Study in Non-small Cell Lung Cancer
November 28, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 24, 2022
From
Arcus Biosciences
Via
Business Wire
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
November 23, 2022
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Upgrades
Via
Benzinga
Arcus Biosciences to Participate in the 5th Annual Evercore ISI HealthCONx Conference
November 14, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 09, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Reports Third Quarter 2022 Financial Results and Provides a Pipeline Update
November 02, 2022
From
Arcus Biosciences
Via
Business Wire
ON Semiconductor, Global Payments And Other Big Losers From Monday
November 01, 2022
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Analysts Turn Bullish On Gilead After Q3 Earnings Surpass Expectations
October 28, 2022
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
October 25, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
October 11, 2022
From
Arcus Biosciences
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Upgrades
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
September 26, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 09, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
August 24, 2022
From
Arcus Biosciences
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.